EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Bacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract

Finn MacLean, Adino Tesfahun Tsegaye, Jessica B Graham, Jessica L Swarts, Sarah C Vick, Nicole B Potchen, Irene Cruz Talavera, Lakshmi Warrier, Julien Dubrulle, Lena K Schroeder, Ayumi Saito, Corinne Mar und 9 weitere

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci184609 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Finn MacLean und 20 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Cervix Uteri, Vagina, Vaginosis, Bacterial. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Bacterial vaginosis (BV) is a dysbiosis of the vaginal microbiome that is prevalent among reproductive-age females worldwide. Adverse health outcomes associated with BV include an increased risk of sexually acquired HIV, yet the immunological mechanisms underlying this association are not well understood. METHODS To investigate BV-driven changes to cervicovaginal tract (CVT) and circulating T cell phenotypes, Kinga Study participants with or without BV provided vaginal tract (VT) and ectocervical (CX) tissue biopsies and PBMC samples. RESULTS High-parameter flow cytometry revealed an increased frequency of cervical CD4 + conventional T (Tconv) cells expressing CCR5 in BV + versus BV – women. However, we found no difference in the number of CD3 + CD4 + CCR5 + cells in the CX or VT of BV + versus BV – individuals, suggesting that BV-driven increased HIV susceptibility may not be solely attributed to increased CVT HIV target cell abundance. Flow cytometry also revealed that individuals with BV had an increased frequency of dysfunctional CX and VT CD39 + Tconv and CX tissue-resident CD69 + CD103 + Tconv cells, reported to be implicated in HIV acquisition risk and replication. Many soluble immune factor differences in the CVT further support that BV elicits diverse and complex CVT immune alterations. CONCLUSION Our comprehensive analysis expands on potential immunological mechanisms that may underlie the adverse health outcomes associated with BV, including increased HIV susceptibility. TRIAL REGISTRATION ClinicalTrials.gov NCT03701802. FUNDING This work was supported by National Institutes of Health grants R01AI131914, R01AI141435, and R01AI129715.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD4-Positive T-LymphocytesCervix UteriVaginaVaginosis, BacterialAdultFemaleHumansAntigens, CDHIV InfectionsReceptors, CCR5

Stichwörter der Autor:innen

AIDS/HIVImmunologyInfectious diseaseT cells

Substanzen

Antigens, CDCCR5 protein, humanReceptors, CCR5

Autor:innen und Institutionen

  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Cellular Imaging Shared Resource, Fred Hutchinson Cancer Center. Seattle, Washington, USA.
  • Department of Internal Medicine-Nephrology, University Hospital Regensburg, Regensburg, Germany.
  • Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Center for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NICHD NIH HHS
  • National Institutes of Health

Zitieren

APA

MacLean, F., Tsegaye, A. T., Graham, J. B., Swarts, J. L., Vick, S. C., Potchen, N. B., Cruz Talavera, I., Warrier, L., Dubrulle, J., Schroeder, L. K., Saito, A., Mar, C., Thomas, K. K., Mack, M., Sabo, M. C., Chohan, B. H., Ngure, K., Mugo, N. R., Lingappa, J. R., …, & Kinga Study Team (2025). Bacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract. Journal of Clinical Investigation. https://doi.org/10.1172/jci184609

Vancouver

MacLean F, Tsegaye AT, Graham JB, Swarts JL, Vick SC, Potchen NB, et al. Bacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract. Journal of Clinical Investigation. 2025. doi:10.1172/jci184609

BibTeX
@article{MacLean2025,
  author = {MacLean, Finn and Tsegaye, Adino Tesfahun and Graham, Jessica B and Swarts, Jessica L and Vick, Sarah C and Potchen, Nicole B and Cruz Talavera, Irene and Warrier, Lakshmi and Dubrulle, Julien and Schroeder, Lena K and Saito, Ayumi and Mar, Corinne and Thomas, Katherine K and Mack, Matthias and Sabo, Michelle C and Chohan, Bhavna H and Ngure, Kenneth and Mugo, Nelly Rwamba and Lingappa, Jairam R and Lund, Jennifer M and Kinga Study Team, Kinga Study Team},
  title = {Bacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci184609}
}
Kostenlos starten →